Prognostic factors in patients with jaw sarcomas
AUTOR(ES)
Vadillo, Rafael Morales, Contreras, Sonia Julia Sacsaquispe, Canales, Janet Ofelia Guevara
FONTE
Brazilian Oral Research
DATA DE PUBLICAÇÃO
2011-10
RESUMO
The aim of this study was to identify the prognostic factors related to the survival of patients with sarcomas of the jaw treated in the Dr. Eduardo Caceres Graziani National Institute for Neoplastic Diseases, Lima, Peru. Age, gender, delay in consultation, diagnostic delay, therapeutic delay, tumor size, tumor location, facial asymmetry, pain, treatment type, and histopathological diagnosis were all evaluated as possible prognostic factors that would influence survival in those with jaw sarcomas. In the analysis, the following was used: mortality tables, Kaplan-Meier's product-limit method, log-rank, and Breslow and Tarone-Ware tests; for the prognostic factors, Cox's Regression Model was used. The overall survival rate, with the patient being free from disease at two years, was 55%, and that at five years was 45%. In the independent analysis of the prognostic factors, four variables were statistically significant in influencing survival: gender (p = 0.043), histopathologic diagnosis (p = 0.019), tumor location (p = 0.019), and treatment type (p = 0.030). According to Cox's Regression Model for the multivariate analysis, statistically significant prognostic factors were: gender (p = 0.086), tumor location (p = 0.020), and treatment type (p = 0.092). Thus, the variables of gender, tumor location, and treatment type were determined to be predictive factors for prognosis of survival.
Documentos Relacionados
- Prognostic factors in patients with intracerebral haematoma.
- Surgical management and prognostic factors in patients with subungual melanoma.
- Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.
- Prognostic factors in patients with breast cancer metastasis in the femur treated surgically
- Patients with soft-tissue sarcomas.